Reduced expression level of Mgmt mRNA and β-catenin gene mutation in rat colon tumors

Anticancer Research

Volumn 26, Issue 4 B, 2006, Pages 2829-2832

  Kinjo, Tatsuya ^a   Suzui, Masumi ^a   Morioka, Takamitsu ^a   Inamine, Morihiko ^a   Kaneshiro, Tatsuya ^a   Arakaki, Junya ^a   Chiba, Itaru ^a   Sunagawa, Nao ^a   Nishimaki, Tadashi ^a   Yoshimi, Naoki ^a  

^a UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

Author keywords

catenin gene mutation; AOM; DSS; Mgmt

Indexed keywords

AZOXYMETHANE; BETA CATENIN; DEXTRAN SULFATE; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON TUMOR; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANIMALS; AZOXYMETHANE; BETA CATENIN; COLONIC NEOPLASMS; DEXTRAN SULFATE; MALE; MUTATION; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RATS; RATS, INBRED F344; RNA, MESSENGER;

EID: 33746721481     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. 6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 50: 6119-6129, 1990.
2. 6-methylguanine and 7-methylguanine formation and persistence in DNA of rats treated with symmetrical dimethylhydrazine. Cancer Res 41: 3967-3972, 1981.
3. 6-methylguanine-DNA-methyltransferase protects Chinese hamster ovary cells from spontaneous G:C to A:T transitions. Cancer Res 52: 6471-6475, 1992.
4. 6- alkylguanine. FASEB J 6: 2302-2310, 1992.
5. Zaidi NH, Pretlow TP, O'Riordan MA, Dumenco LL, Allay E and Gerson SL: Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis 16: 451-456, 1995.
6. Wali RK, Skarosi S, Hart J, Zhang Y, Dolan ME, Moschel RC, Nguyen L, Mustafi R, Brasitus TA and Bissonnette M: Inhibition of O(6)-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats. Carcinogenesis 20: 2355-2360, 1999.
7. Whitehall VL, Walsh MD, Young J, Leggett BA and Jass JR: Methylation of O-6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res 61: 827-830, 2001.
8. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275: 1787-1790, 1997.
9. Takahashi M and Wakabayashi K: Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 95: 475-480, 2004.
10. Suzui M, Ushijima T, Dashwood RH, Yoshimi N, Sugimura T, Mori H and Nagao M: Frequent mutations of the rat β-catenin gene in colon cancers induced by methylazoxymethanol acetate plus 1-hydroxyanthraquinone. Mol Carcinog 24: 232-237, 1999.
11. Kinjo T, Suzui M, Morioka T, Nabandith V, Inamine M, Kaneshiro T, Arakaki T, Nishimaki T and Yoshimi N: Distribution of preneoplastic lesions and tumors and β-catenin gene mutations in the colon carcinomas induced by 1,2-dimethylhydrazine plus dextran sulfate sodium. J Exp Clin Cancer Res 25: 207-213, 2006.
12. Suzui M, Inamine M, Kaneshiro T, Morioka T, Yoshimi N, Suzuki R, Kohno H and Tanaka T: Indole-3-carbinol inhibits the growth of human colon carcinoma cells but enhances the tumor multiplicity and volume of azoxymethane-induced rat colon carcinogenesis. Int J Oncol 27: 1391-1399, 2005.
13. Suzui M, Sugie S, Mori H, Okuno M, Tanaka T and Moriwaki H: Different mutation status of the β-catenin gene in carcinogen-induced colon, brain, and oral tumors in rats. Mol Carcinog 32: 206-212, 2001.
14. 6-methylguanine by alkylation of rat liver, colon, and kidney DNA following administration of 1,2-dimethylhydrazine. Cancer Res 37: 4082-4087, 1977.
15. Swenberg JA, Cooper HK, Bucheler J and Kleihues P: 1,2-Dimethylhydrazine- induced methylation of DNA bases in various rat organs and the effect of pretreatment with disulfiram. Cancer Res 39: 465-467, 1979.
16. Jackson PE, O'Connor PJ, Cooper DP, Margison GP and Povey AC: Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine. Carcinogenesis 24: 527-533, 2003.
17. Blum CA, Xu M, Orner GA, Dario Diaz G, Li Q, Dashwood WM, Bailey GS and Dashwood RH: Promotion versus suppression of rat colon carcinogenesis by chlorophyllin and chlorophyll: modulation of apoptosis, cell proliferation, and β-catenin/Tcf signaling. Mutat Res 525-524: 217-223, 2003.
18. Suzui M and Yoshimi N: New insights into molecular carcinogenesis. In: Carcinogenesis and Modification of Carcinogenesis. Tanaka T and Tsuda H (eds.). Kerala, Research Signpost, pp. 33-48, 2005.
19. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59: 793-797, 1999.
20. Herfarth KK, Brent TP, Danam RP, Remack JS, Kodner IJ, Wells SA Jr and Goodfellow PJ: A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers. Mol Carcinog 24: 90-98, 1999.
21. Koga Y, Kitajima Y, Miyoshi A, Sato K, Kitahara K, Soejima H and Miyazaki K: Tumor progression through epigenetic gene silencing of O(6)-methylguanine- DNA methyltransferase in human biliary tract cancers. Ann Surg Oncol 12: 354-363, 2005.
22. Halford S, Rowan A, Sawyer E, Talbot I and Tomlinson I: O(6)-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions. Gut 54: 797-802, 2005.
23. Zhao W, Soejima H, Higashimoto K, Nakagawachi T, Urano T, Kudo S, Matsukura S, Matsuo S, Joh K and Mukai T: The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island. J Biochem (Tokyo) 137: 431-440, 2005.
24. Yamada Y, Yoshimi N, Hirose Y, Kawabata K, Matsunaga K, Shimizu M, Hara A and Mori H: Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res 60: 3323-3327, 2000.
25. Femia AP, Bendinelli B, Giannini A, Salvadori M, Pinzani P, Dolara P and Caderni G: Mucin-depleted foci have β-catenin gene mutations, altered expression of its protein, and are dose-and time-dependent in the colon of 1,2-dimethylhydrazine-treated rats. Int J Cancer 116: 9-15, 2005.
26. Yoshimi N, Morioka T, Kinjo T, Inamine M, Kaneshiro T, Shimizu T, Suzui M, Yamada Y and Mori H: Histological and immunohistochemical observations of mucin-depleted foci (MDF) stained with Alcian blue, in rat colon carcinogenesis induced with 1,2-dimethylhydrazine dihydrochloride. Cancer Sci 95: 792-797, 2004.